Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Norland Medical Systems (NRLD) -- Ignore unavailable to you. Want to Upgrade?

To: Jason Loren Bauer who wrote (36)	6/1/1997 6:18:00 PM
From: J. P.	Respond to of 47

I'm sure you meant "wary", a Freudian slip perhaps... I checked on this thread for old times sake. Still trading in that old range. Remember my posts from way back when, HOLX and LUNR, their main competitors have a lock on the lions share of the market because they specialize in axial bone densitometry, not radial bone densitometry (wrists) as NRLD does. Axial being the preffered diagnostic tool for osteoporosis, and getting a larger fee for the procedure. As long as it stays in the trading range (6-8) and you can pick off a percentage who cares, right? And wow, did LUNR ever get hammered for their sins of that penny! This is a tough business! Regards, J.P.